PG
48
-5
UNM
50
-3
CMCSA
39
7
FE
50
-2
KIM
58
7
HSY
34
-3
TROW
56
-2
IR
63
3
APH
58
2
XEL
39
-4
PRU
74
-2
IP
34
-5
AFL
39
-2
EXC
50
-3
WY
45
6
EBAY
52
5
CCL
58
3
FAST
34
-12
VFC
72
-7
ITW
34
-5
PG
48
-5
UNM
50
-3
CMCSA
39
7
FE
50
-2
KIM
58
7
HSY
34
-3
TROW
56
-2
IR
63
3
APH
58
2
XEL
39
-4
PRU
74
-2
IP
34
-5
AFL
39
-2
EXC
50
-3
WY
45
6
EBAY
52
5
CCL
58
3
FAST
34
-12
VFC
72
-7
ITW
34
-5
Financhill
Back

DocuSign, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
67

DOCU
DocuSign, Inc.

Last Price:
$66.01
Seasonality Move:
12.2%
Buy
90

KYMR
Kymera Therapeutics, Inc.

Last Price:
$94.38
Seasonality Move:
7.7%
Buy
67
DocuSign, Inc. (DOCU) is a Buy

Is DocuSign, Inc. a Buy, Sell or Hold?

  • The current DocuSign, Inc. [DOCU] share price is $66.04. The Score for DOCU is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • DOCU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
90
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

DOCU Stock Price Chart

What is DocuSign, Inc.'s stock price today?

  • The DocuSign, Inc. share price today is $66.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DOCU is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $94.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

DOCU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.59 Sell
Relative Strength Index (14 RSI): 42.69 Sell
Chaikin Money Flow: 3412963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (65.85 - 70.49) Sell
Bollinger Bands (100): (67.68 - 78.8) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 86.88 Buy
Chaikin Money Flow: -462379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.8 - 71.72) Buy
Bollinger Bands (100): (43.38 - 63.26) Buy

DOCU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.61 Sell
20-day SMA: 67.5 Sell
50-day SMA: 69.43 Sell
200-day SMA: 77.12 Sell
8-day EMA: 67.84 Sell
20-day EMA: 68.17 Sell
50-day EMA: 70.05 Sell
200-day EMA: 74.55 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70 Buy
20-day SMA: 66.61 Buy
50-day SMA: 61.97 Buy
200-day SMA: 44.25 Buy
8-day EMA: 72.36 Buy
20-day EMA: 67.57 Buy
50-day EMA: 61.93 Buy
200-day EMA: 49.42 Buy

DocuSign, Inc. Earnings Growth & DOCU Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.66 per share, and an increase next year of $0.24 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

DocuSign, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):